Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment
Year: 2021
Type: article
Source: Annals of Internal Medicine
DOI: 10.7326/l20-1455
Institution: Janssen Research & Development (United States)
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3137318924
